3.9 Article

Rates of HCV Treatment Eligibility Among HCV-Monoinfected and HCV/HIV-Coinfected Patients in Tertiary Care Referral Centers

Related references

Note: Only part of the references are listed.
Article Substance Abuse

Barriers associated with the treatment of hepatitis C virus infection among illicit drug users

Jason Grebely et al.

DRUG AND ALCOHOL DEPENDENCE (2008)

Article Gastroenterology & Hepatology

Rate and predictors of treatment prescription for hepatitis C

Adeel A. Butt et al.

Article Gastroenterology & Hepatology

Treatment of hepatitis C virus and human immunodeficiency virus coinfection: from large trials to real life

P. Cacoub et al.

JOURNAL OF VIRAL HEPATITIS (2006)

Article Gastroenterology & Hepatology

Rates and predictors of hepatitis C virus treatment in HCV-HIV-coinfected subjects

A. A. Butt et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)

Article Health Care Sciences & Services

Barriers to the treatment of hepatitis C

JA Morrill et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2005)

Article Gastroenterology & Hepatology

Reasons for non-treatment of hepatitis C in veterans in care

AA Butt et al.

JOURNAL OF VIRAL HEPATITIS (2005)

Article Gastroenterology & Hepatology

Hepatitis C virus-infected patients report communication problems with physicians

S Zickmund et al.

HEPATOLOGY (2004)

Review Gastroenterology & Hepatology

Diagnosis, management, and treatment of hepatitis C

DB Strader et al.

HEPATOLOGY (2004)

Article Medicine, General & Internal

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients

FJ Torriani et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)

Article Medicine, General & Internal

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection.

MW Fried et al.

NEW ENGLAND JOURNAL OF MEDICINE (2002)

Article Medicine, General & Internal

Peginterferon alfa-2a in patients with chronic hepatitis C

S Zeuzem et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)

Review Gastroenterology & Hepatology

Antiviral therapy for patients with chronic hepatitis C

J Heathcote

SEMINARS IN LIVER DISEASE (2000)